A novel approach to target inflammatory diseases
Inotrem is supported by top-tier international investors.
INOTREM S.A | 114 rue la Boétie 75008 PARIS
Inotrem 2018 – Legal notices
INOTREM S.A | 114 rue la Boétie 75008 PARIS
Inotrem 2018 – Legal notices